<DOC>
	<DOCNO>NCT00143702</DOCNO>
	<brief_summary>The purpose study determine best way treat people d4T ( stavudine ) high level lactic acid . Switching d4T abacavir assess . Adding riboflavin thiamine also assess . Participants randomly assign one four group : - Group 1 participant continue take d4T part antiretroviral ( ARV ) regimen , give vitamin supplement - Group 2 continue take d4T without vitamin supplement - Group 3 switch d4T abacavir receive vitamin - Group 4 switch d4T abacavir without vitamin supplement . The study plan involve eighty participant Canada Argentina treatment period 16 week follow-up visit week 24 .</brief_summary>
	<brief_title>D4T Abacavir Plus Vitamin Enhancement HIV-Infected Patients ( DAVE )</brief_title>
	<detailed_description />
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Acidosis , Lactic</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Thiamine</mesh_term>
	<criteria>Be HIVpositive Be 18 year age old Have viral load equal 50 copies/mL Have d4Tcontaining multiple drug regimen ( least three agent total ) least six month Have stable ARV regimen three month prior enrollment Have venous lactic acid measurement 2.1 mmol/L within three month prior enrollment two consecutive measurement 2.1 low 6.0 within twoweek period screen Be willing discontinue Lcarnitine and/or coenzyme Q10 Be willing able provide inform consent Pregnancy breastfeed Venous lactic acid equal 6.0 mmol/L Previous exposure abacavir Virologic rebound previous regimen consist dual triple nucleoside reverse transcriptase inhibitor ( NRTIs ) Use hydroxyurea within three month prior enrollment Use metformin Any acute cardiopulmonary illness infection New AIDSdefining illness diagnose within four week enrollment Riboflavin thiamine supplementation 20 mg/day within 30 day prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Elevated Lactic Acid</keyword>
</DOC>